Objective. To assess the efficacy of monoclonal anti-tumour necrosis factor (TNF)-α agents
in patients with anterior uveitis (AU) in terms of decrease of recurrences, variation of visual …

Background: To assess the efficacy and safety of immunomodulatory drugs in patients with
noninfectious anterior uveitis (AU). Methods: Systematic review of studies were retrieved …

Purpose: TNF alpha inhibitors have revolutionized the care of vision-threatening uveitis. This
study evaluated the efficacy of adalimumab (ADA) for the treatment of refractory …

Effectiveness of infliximab, adalimumab and golimumab for non-infectious refractory uveitis in
adults. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu …

Objective To compare the efficacy and safety of Disease-modifying antirheumatic drugs
(DMARDs) and anti-TNF-α agents in patients with non-infectious non-anterior uveitis …

Objective. The aim of the study was to evaluate the efficacy of golimumab (GOL) and
certolizumab pegol (CZP) as additional treatment options for the treatment of uveitis …

To compare the efficacy of adalimumab (ADA) and infliximab (IFX) in patients with non-
infectious intermediate uveitis, posterior uveitis, and panuveitis. Demographic, clinical …

Objective Tumour necrosis factor (TNF) blockers have been demonstrated to be effective in
the treatment of systemic and ocular inflammatory diseases. We conducted a prospective …

Purpose: To assess the efficacy of anti-TNF alpha (TNF-α) therapy in patients with non-
infectious uveitis. Methods: This was a monocentric observational study of 21 patients with …

Objective To analyze the factors associated with response to anti–tumor necrosis factor (anti‐
TNF) treatment and compare the efficacy and safety of infliximab (IFX) and adalimumab …